Comparison of Kaplan-Meier estimates of overall survival in MDS classified according to the refined WHO proposal (n = 333) (P < .01).

Subgroups: RA (n = 76), RARS (n = 21), RC+Dys (n = 96), RAEB I (n = 56), RAEB II (n = 82).